Interventional studies are often possible and so are particularly customized to evaluate direct impacts of treatment or preventive actions on disease. - "Our study exposed the very important part of the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, like OTX015 https://abbv-744brd4inhibitioninc80134.sharebyblog.com/31911127/a-review-of-abbv-744-in-combination-with-immunotherapy